Atlas Trials

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

Clinical trial NCT02715115 · COMPLETED

Trial details

NCT number
NCT02715115
Sponsor
Neuren Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rett Syndrome
Start date
2016-03-01
Primary completion
2017-01-05
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.